Kenneth Greathouse, Director at Zosano Pharma Corp (ZSAN), bought 55,000 shares at $0.61 ($34K) on 2017-12-06, disclosed to the SEC on 2017-12-08.
Open-market purchase of $34k ZSAN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ZSAN | BUY | 2017-11-16 | $31K | — | Filing → |